Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H31N5O2 |
Molecular Weight | 445.5566 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(NCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)=C(C(C)=N1)[N+]([O-])=O
InChI
InChIKey=QMCHYTVPUAJEMM-UHFFFAOYSA-N
InChI=1S/C26H31N5O2/c1-20-19-24(25(31(32)33)21(2)28-20)27-13-14-29-15-17-30(18-16-29)26(22-9-5-3-6-10-22)23-11-7-4-8-12-23/h3-12,19,26H,13-18H2,1-2H3,(H,27,28)
Molecular Formula | C26H31N5O2 |
Molecular Weight | 445.5566 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Elbanizine [HWA 214] is an antihistamine which was undergoing preclinical trials with Hoechst Marion Roussel in Germany for the treatment of allergic asthma. Elbanizine does not have such drawbacks as causing drowsiness or being effective only as a prophylactic drug, and could provide advantages over other non-sedative compounds, such as terfenadine and astemizole, in that it is water soluble and thus can be administered through inhalation or through intravenous application.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:37:08 GMT 2023
by
admin
on
Fri Dec 15 15:37:08 GMT 2023
|
Record UNII |
S39YD087F9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06478MIG
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
S39YD087F9
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
6321
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
208913
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
100000080540
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
C73050
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104192
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
DTXSID20149349
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY | |||
|
110629-41-9
Created by
admin on Fri Dec 15 15:37:08 GMT 2023 , Edited by admin on Fri Dec 15 15:37:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |